Trial Profile
Phase I study of KRP-AM1977X -Penetration of AM-1977 into otorhinolaryngological tissues
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Dec 2021
Price :
$35
*
At a glance
- Drugs Lascufloxacin (Primary)
- Indications Community-acquired pneumonia
- Focus Pharmacokinetics
- Sponsors Kyorin Pharmaceutical
- 02 Nov 2016 Status changed from active, no longer recruiting to completed.
- 14 Mar 2016 New trial record